These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15300574)

  • 1. Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening.
    Kanaoka S; Yoshida K; Miura N; Sugimura H; Kajimura M
    Gastroenterology; 2004 Aug; 127(2):422-7. PubMed ID: 15300574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
    Takai T; Kanaoka S; Yoshida K; Hamaya Y; Ikuma M; Miura N; Sugimura H; Kajimura M; Hishida A
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1888-93. PubMed ID: 19505922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients.
    Shimada R; Iinuma H; Akahane T; Horiuchi A; Watanabe T
    Oncol Rep; 2012 Apr; 27(4):947-53. PubMed ID: 22267181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAS.
    Oberg AN; Lindmark GE; Israelsson AC; Hammarström SG; Hammarström ML
    Int J Cancer; 2004 Aug; 111(1):101-10. PubMed ID: 15185350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps.
    Leung WK; To KF; Man EP; Chan MW; Hui AJ; Ng SS; Lau JY; Sung JJ
    Am J Gastroenterol; 2007 May; 102(5):1070-6. PubMed ID: 17378912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Accuracy of a Qualitative Fecal Immunochemical Test Varies With Location of Neoplasia But Not Number of Specimens.
    Wong MC; Ching JY; Chan VC; Lam TY; Shum JP; Luk AK; Wong SS; Ng SC; Ng SS; Wu JC; Chan FK; Sung JJ
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1472-9. PubMed ID: 25724708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer.
    Hamaya Y; Yoshida K; Takai T; Ikuma M; Hishida A; Kanaoka S
    Br J Cancer; 2010 Mar; 102(5):916-21. PubMed ID: 20145612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of colorectal cancer - role of gastrin and cyclooxygenase-2.
    Hartwich J; Konturek SJ; Pierzchalski P; Zuchowicz M; Konturek PC; Bielański W; Marlicz K; Starzyńska T; Ławniczak M
    Med Sci Monit; 2001; 7(6):1171-81. PubMed ID: 11687726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progastrin and cyclooxygenase-2 in colorectal cancer.
    Konturek PC; Bielanski W; Konturek SJ; Hartwich A; Pierzchalski P; Gonciarz M; Marlicz K; Starzynska T; Zuchowicz M; Darasz Z; Götze JP; Rehfeld JF; Hahn EG
    Dig Dis Sci; 2002 Sep; 47(9):1984-91. PubMed ID: 12353842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
    Lohsiriwat V; Thavichaigarn P; Awapittaya B
    J Med Assoc Thai; 2007 Nov; 90(11):2291-5. PubMed ID: 18181309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker selection for detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR.
    Ohlsson L; Hammarström ML; Israelsson A; Näslund L; Oberg A; Lindmark G; Hammarström S
    Br J Cancer; 2006 Jul; 95(2):218-25. PubMed ID: 16755296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of colorectal cancer cells from feces using quantitative real-time RT-PCR for colorectal cancer diagnosis.
    Koga Y; Yasunaga M; Moriya Y; Akasu T; Fujita S; Yamamoto S; Kozu T; Baba H; Matsumura Y
    Cancer Sci; 2008 Oct; 99(10):1977-83. PubMed ID: 19016757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.
    Shen C; Hu L; Xia L; Li Y
    Jpn J Clin Oncol; 2008 Nov; 38(11):770-6. PubMed ID: 18845519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of integrin alpha 6 transcripts in a stool mRNA assay for the detection of colorectal cancers at curable stages.
    Beaulieu JF; Herring E; Kanaoka S; Tremblay É
    Oncotarget; 2016 Mar; 7(12):14684-92. PubMed ID: 26895101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinants of cetuximab efficacy.
    Vallböhmer D; Zhang W; Gordon M; Yang DY; Yun J; Press OA; Rhodes KE; Sherrod AE; Iqbal S; Danenberg KD; Groshen S; Lenz HJ
    J Clin Oncol; 2005 May; 23(15):3536-44. PubMed ID: 15908664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
    Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
    Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
    de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ
    Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EP1-4 subtype, COX and PPAR gamma receptor expression in colorectal cancer in prediction of disease-specific mortality.
    Gustafsson A; Hansson E; Kressner U; Nordgren S; Andersson M; Wang W; Lönnroth C; Lundholm K
    Int J Cancer; 2007 Jul; 121(2):232-40. PubMed ID: 17290397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.